- Home
- CYN vs RADX Comparison
CYN vs RADX Comparison
Compare CYN & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYN
- RADX
- Stock Information
- Founded
- CYN 2013
- RADX 2021
- Country
- CYN United States
- RADX Australia
- Employees
- CYN N/A
- RADX N/A
- Industry
- CYN EDP Services
- RADX
- Sector
- CYN Technology
- RADX
- Exchange
- CYN Nasdaq
- RADX NYSE
- Market Cap
- CYN 28.0M
- RADX 32.5M
- IPO Year
- CYN 2021
- RADX N/A
- Fundamental
- Price
- CYN $7.08
- RADX $4.61
- Analyst Decision
- CYN
- RADX Strong Buy
- Analyst Count
- CYN 0
- RADX 3
- Target Price
- CYN N/A
- RADX $15.00
- AVG Volume (30 Days)
- CYN 1.2M
- RADX 17.9K
- Earning Date
- CYN 08-06-2025
- RADX 02-26-2025
- Dividend Yield
- CYN N/A
- RADX N/A
- EPS Growth
- CYN N/A
- RADX N/A
- EPS
- CYN N/A
- RADX N/A
- Revenue
- CYN $409,777.00
- RADX $204,609.00
- Revenue This Year
- CYN $1,162.03
- RADX N/A
- Revenue Next Year
- CYN $427.83
- RADX N/A
- P/E Ratio
- CYN N/A
- RADX N/A
- Revenue Growth
- CYN N/A
- RADX N/A
- 52 Week Low
- CYN $3.62
- RADX $3.50
- 52 Week High
- CYN $1,312.50
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- CYN 39.27
- RADX N/A
- Support Level
- CYN $8.20
- RADX N/A
- Resistance Level
- CYN $10.04
- RADX N/A
- Average True Range (ATR)
- CYN 0.67
- RADX 0.00
- MACD
- CYN -0.43
- RADX 0.00
- Stochastic Oscillator
- CYN 0.79
- RADX 0.00
About CYN Cyngn Inc.
Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.